{
    "2018-12-26": [
        [
            {
                "time": "",
                "original_text": "贝达药业：盐酸恩沙替尼药品注册申请受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盐酸恩沙替尼",
                        "药品注册",
                        "申请受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)收到CDE签发的关于盐酸恩沙替尼原料药和制剂的补充资料通知书",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "CDE",
                        "盐酸恩沙替尼",
                        "原料药",
                        "制剂",
                        "补充资料通知书"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}